Policy
-
Policy Matters
Research Advocacy During COVID-19Continued federal funding to support biomedical research, including cancer research, is vitally important during the pandemic.
by Brandon Leonard, MA, and Marc Johnson, MPP
-
Immunotherapy Options for Breast CancerTwo immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
-
Q&A
Up for DebateHematologist-oncologist Vinayak K. Prasad describes his positions on cancer research and policy in a recently published book.
by Marci A. Landsmann
-
Cancer and COVID-19 VaccinationAmid continued research showing the impact of COVID-19 on people with cancer, patients are asking when they should get a COVID-19 vaccine.
by Marci A. Landsmann
-
Colorectal Cancer Screenings at HomeStool-based tests could increase access to colorectal cancer screening.
by Jen Tota McGivney
-
Policy Matters
Cancer Scientists Support COVID-19 ResponseResearchers study ways to improve telehealth capabilities, clinical trials and health disparities.
by Trevan Locke, PhD
-
Forward Look
Creating More Inclusive Clinical TrialsThe Clinical Treatment Act aims to include more Medicaid recipients.
by Jen Tota McGivney
-
Policy Matters
The E-Cigarette Regulatory LandscapeThe FDA is taking several steps to restrict and reduce e-cigarette use among youth.
by Carmine S. Leggett, PhD
-
Learning Medicare’s ABCDsMedicare was established to help provide affordable health care coverage for older Americans. But Medicare beneficiaries with cancer can still face financial burdens related to their care.
by Kate Yandell
-
A Missed ConversationDespite national guidelines urging oncologists to bring up risks of infertility posed by cancer treatment, many young cancer patients are never told about these risks or counseled on their fertility preservation options.
by Marcus A. Banks
